Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECIOUS stroke complication prevention trial
2015-003179-32Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetaminophen, ceftriaxone and metoclopramide in ischemic stroke and intracerebral hemorrhage (ICH) (8 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Modified Rankin Scale at 90 days. Started Nov 2015; status: completed.
02
Drugs
acetaminophenceftriaxonemetoclopramide
03
Conditions
ischemic strokeintracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2015-003179-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003179-32.